Evidence map›Paper›PMID 42841133›Full record

ReviewDementia & neuropsychologia2026

Prior COVID-19 vaccination and cognitive outcomes after SARS-CoV-2 infection: a mini-review.

Lucas Gomes da Silva, Jordano César Milagres Oliveira, Bruna Carmeni Di Fini, Aline Arantes Porto, Danielle de Souza Costa, Débora Marques de Miranda, Marco Aurélio Romano-Silva, Jonas Jardim de Paula

Abstract readReview
In one paragraph

Review in Dementia & neuropsychologia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lucas Gomes da SilvaUniversidade Federal de Minas Gerais, Faculdade de Medicina, Programa de Pós-Graduação em Medicina Molecular, Belo Horizonte MG, Brazil.ORCID https://orcid.org/0000-0002-7314-1977
Jordano César Milagres OliveiraUniversidade Federal de Minas Gerais, Faculdade de Medicina, Programa de Pós-Graduação em Medicina Molecular, Belo Horizonte MG, Brazil.ORCID https://orcid.org/0000-0001-8723-7251
Bruna Carmeni Di FiniUniversidade Federal de Minas Gerais, Faculdade de Medicina, Programa de Pós-Graduação em Medicina Molecular, Belo Horizonte MG, Brazil.ORCID https://orcid.org/0000-0002-3382-5186
Aline Arantes PortoUniversidade Federal de Minas Gerais, Faculdade de Medicina, Instituto Nacional de Ciência e Tecnologia em Neurotecnologia Responsável, Belo Horizonte MG, Brazil.ORCID https://orcid.org/0000-0002-8281-6729
Danielle de Souza CostaUniversidade Federal de Minas Gerais, Faculdade de Medicina, Instituto Nacional de Ciência e Tecnologia em Neurotecnologia Responsável, Belo Horizonte MG, Brazil.ORCID https://orcid.org/0000-0001-6883-5133
Débora Marques de MirandaUniversidade Federal de Minas Gerais, Faculdade de Medicina, Programa de Pós-Graduação em Medicina Molecular, Belo Horizonte MG, Brazil.ORCID https://orcid.org/0000-0002-7081-8401
Marco Aurélio Romano-SilvaUniversidade Federal de Minas Gerais, Faculdade de Medicina, Programa de Pós-Graduação em Medicina Molecular, Belo Horizonte MG, Brazil.ORCID https://orcid.org/0000-0002-6558-4639
Jonas Jardim de PaulaUniversidade Federal de Minas Gerais, Faculdade de Medicina, Programa de Pós-Graduação em Medicina Molecular, Belo Horizonte MG, Brazil.ORCID https://orcid.org/0000-0001-5530-2346

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 infection has been frequently associated with cognitive deficits that persist for months after the acute phase, but the impact of vaccination on preventing these deficits remains uncertain. Evidence suggests that immunization reduces the incidence and severity of post-COVID symptoms, yet few studies have evaluated its influence on cognition using objective measures. To address this gap, a mini-review was conducted using a systematic search strategy, following PRISMA recommendations where applicable, with a protocol registered in PROSPERO (CRD42025636772). Searches were carried out in the PubMed/MEDLINE and Scopus databases, and eligible studies were those that assessed cognition using objective measures and compared vaccinated and unvaccinated individuals at the time of infection. A total of 1,796 records were identified, of which only five met the inclusion criteria. The included studies varied considerably in cognitive assessment tools, study designs, and sample sizes. Four of the five studies found no association between prior vaccination and cognitive deficits, whereas the only study that identified a subtle difference among individuals who had received at least two doses of the vaccine had a substantially larger sample than all the others combined. Methodological inconsistencies in cognitive assessment, variability in the definitions of vaccination status, and the lack of stratification by specific cognitive domains limit the interpretation of the current findings. Although vaccination may play a role in protecting against cognitive deficits following COVID-19 infection, the evidence remains limited and inconclusive. Further studies with standardized definitions of vaccination status and comprehensive objective assessments are needed to clarify this relationship.

Indexed as

CognitionCOVID-19Memory DisordersPost-Acute COVID-19 SyndromeVaccination.

Identifiers

PMID42841133
PMCPMC13641761

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.